Negative Regulation of JNK Signaling by the Tumor Suppressor CYLD The Journal of Biological Chemistry Authors: William Reily, Minying Zhang, and Shao-

Slides:



Advertisements
Similar presentations
Inhibition of NF-kB by ZAS3, a zinc-finger protein that also binds to the kB motif Presenters: Melissa Sherman & Troy Williams Authors: Joung-Woo Hong,
Advertisements

ApoptosisNecrosis Apoptosis is a form of programmed cell death Apoptosis is responsible for the formation of digits in the developing mouse paw. Apoptotic.
Differential Immune Modulatory Activity of P. Aeruginosa Quorum- sensing Signal Molecules Presented by Inderdeep S. Atwal.
TNF superfamily TNF: produced by macrophages, monocytes, lymphocytes, fibroblasts upon inflammation, infection, injury, environmental challenges.
HUMAN IMMUNODEFICIENCY VIRUS-1 TAT PROTEIN UPREGULATES IL-6 AND IL-8 EXPRESSION IN HUMAN BREAST CANCER CELLS Yong Woo Lee 1, Natasha Kyprianou 1, Avindra.
Introduction Tumor necrosis factor-  (TNF  ) is a pro-inflammatory cytokine important in immune responses TNF  inhibits cAMP-stimulated Cyp17 transcription.
NOTES: CH 18 part 2 - The Molecular Biology of Cancer
CONTEXT SPECIFIC ROLE OF DEUBIQUITYLASE ENZYME, USP9X, IN HEAD AND NECK CANCER Devathri Nanayakkara Eskitis Institute for Drug Discovery Griffith University.
Role of Mitogen-activated Protein Kinase Phosphatase During the Cellular Response to Gentoxic Stress :Inhibition of c-Jun N-Terminal Kinase Activity and.
Sh-luc shSCP1-1 * IB: c-Myc IB: Tubulin shSCP1-2 IB: p-Ser KD 70KD 60KD 70KD (abnova) sh-luc shSCP1-1 * IB: c-Myc IB: Tubulin shSCP1-2.
mM aspirin “IkB concentrations in the salicylate cell extracts were the same as in control whereas IkB was reduced in activated cells without salicylate”
Cytokines To highlight the major cytokines that are mediators of: (i) natural immunity, (ii) adaptive immunity and (iii) hematopoesis.
The Problem of Cancer. What are cancer cells ? Cancerous growth involves unrestrained proliferation (malignancy) and spread (metastasis). Caused by: mutations.
Piceatannol, a catechol-type polyphenol, inhibits phorbol ester-induced NF-kB activation and cyclooxygenase-2 expression in human breast epithelial cells.
Up-Regulation of Activating Transcription Factor-5 Suppresses SAP Expression to Activate T Cells in Hemophagocytic Syndrome Associated with Epstein-Barr.
Innate immune-signaling cascades and evidence for upregulation in brain following AIE exposure. Innate immune-signaling cascades and evidence for upregulation.
Volume 9, Issue 5, Pages (November 1998)
Volume 134, Issue 4, Pages (April 2008)
Syk Mediates IL−17-Induced CCL20 Expression by Targeting Act1-Dependent K63- Linked Ubiquitination of TRAF6  Nan-Lin Wu, Duen-Yi Huang, Hsin-Ni Tsou, Ying-Cing.
Somatic Mutations in MAP3K5 Attenuate Its Proapoptotic Function in Melanoma through Increased Binding to Thioredoxin  Todd D. Prickett, Brad Zerlanko,
Yongping Shao, Kaitlyn Le, Hanyin Cheng, Andrew E. Aplin 
Volume 142, Issue 7, Pages e6 (June 2012)
House Dust Mite Increases pro-Th2 Cytokines IL-25 and IL-33 via the Activation of TLR1/6 Signaling  Yong Hyun Jang, Jin Kyeong Choi, Meiling Jin, Young-Ae.
Volume 25, Issue 6, Pages (December 2006)
Toll-like receptors: Applications to dermatologic disease
Characterization of TNF-α– and IL-17A–Mediated Synergistic Induction of DEFB4 Gene Expression in Human Keratinocytes through IκBζ  Claus Johansen, Trine.
Volume 33, Issue 2, Pages (January 2009)
Volume 9, Issue 1, Pages (January 2002)
Whipping NF-κB to Submission via GADD45 and MKK7
Volume 19, Issue 2, Pages (February 2017)
Shitao Li, Lingyan Wang, Michael A. Berman, Ye Zhang, Martin E. Dorf 
Volume 142, Issue 7, Pages e6 (June 2012)
MEKK4 Sequesters RIP2 to Dictate NOD2 Signal Specificity
A Liver Full of JNK: Signaling in Regulation of Cell Function and Disease Pathogenesis, and Clinical Approaches  Ekihiro Seki, David A. Brenner, Michael.
ASK1 Is Essential for JNK/SAPK Activation by TRAF2
IGF-II-Mediated COX-2 Gene Expression in Human Keratinocytes Through Extracellular Signal-Regulated Kinase Pathway  Hye Jung Kim, Tae-Yoon Kim  Journal.
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Galectin-7 Regulates Keratinocyte Proliferation and Differentiation through JNK-miR- 203-p63 Signaling  Hung-Lin Chen, Po-Cheng Chiang, Chia-Hui Lo, Yuan-Hsin.
Identification and Characterization of an IκB Kinase
SUMO Promotes HDAC-Mediated Transcriptional Repression
Experimental Hematology
SMRT Derepression by the IκB Kinase α
Volume 34, Issue 4, Pages (May 2009)
Glycogen Synthase Kinase 3β Regulates IRF3 Transcription Factor-Mediated Antiviral Response via Activation of the Kinase TBK1  Cao-Qi Lei, Bo Zhong, Yu.
Nanna Fyhrquist, Sampsa Matikainen, Antti Lauerma 
Volume 11, Issue 6, Pages (June 2003)
Volume 19, Issue 5, Pages (November 2003)
Role of NF-κB Activity in Apoptotic Response of Keratinocytes Mediated by Interferon-γ, Tumor Necrosis Factor-α, and Tumor-Necrosis-Factor-Related Apoptosis-Inducing.
Volume 30, Issue 3, Pages (March 2009)
Volume 19, Issue 5, Pages (September 2005)
NF-κB1/p105 Regulates Lipopolysaccharide-Stimulated MAP Kinase Signaling by Governing the Stability and Function of the Tpl2 Kinase  Michael R. Waterfield,
NF-κB activation in pathogenesis and therapy of cancer.
Volume 119, Issue 1, Pages (July 2000)
Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart
Volume 12, Issue 5, Pages (November 2003)
Rsk1 mediates a MEK–MAP kinase cell survival signal
Volume 21, Issue 6, Pages (November 2017)
Volume 128, Issue 7, Pages (June 2005)
Volume 125, Issue 4, Pages (May 2006)
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
Volume 8, Issue 8, Pages (January 2001)
Components and outcomes of selected TNF-superfamily signalling pathways. Components and outcomes of selected TNF-superfamily signalling pathways. (Left)
Volume 16, Issue 16, Pages (August 2006)
Deon G. Uffort, Elizabeth A. Grimm, Julie A. Ellerhorst 
Volume 3, Issue 3, Pages (March 2013)
Macrophages, Immunity, and Metabolic Disease
Phosphorylation of CBP by IKKα Promotes Cell Growth by Switching the Binding Preference of CBP from p53 to NF-κB  Wei-Chien Huang, Tsai-Kai Ju, Mien-Chie.
Runa Sur, Peter A. Lyte, Michael D. Southall 
Jörg Hartkamp, Brian Carpenter, Stefan G.E. Roberts  Molecular Cell 
Volume 10, Issue 2, Pages (February 1999)
Presentation transcript:

Negative Regulation of JNK Signaling by the Tumor Suppressor CYLD The Journal of Biological Chemistry Authors: William Reily, Minying Zhang, and Shao- Cong Sun Presentors: Ronesha Franklin Kimberly Kimbrough

Objective of Experiment ► To investigate the function of endogenous CYLD in the regulation of cell signaling.

What is CYLD? ► CYLD is a tumor suppressor that is mutated in familial cylindromatosis.  Familial cylindromatosis is a genetic syndrome in which numerous benign tumors of skin adnexa develop, principally on the head and neck. This disorder is inherited in an autosomal manner and is caused by mutation of CYLD gene on chromosome 16q12-q13. ► Results in a pile up of cells.

CYLD Functions ► CYLD  Is a deubiquitinating enzyme that negatively regulates NFkB activation by TNFR family members. ► Deubiquitinating enzymes remove ubiqutin, a small molecule that serves as a tag that signals proteins to proteasomes for degradation.  Inhibits the ubiquitnation of certain signaling molecules, including members of the tumor necrosis factor receptor-associated factor (TRAF) family.

TRAF Function ► TRAFs activate downstream signaling cascades and lead to activation of IKK and 3 families of MAPKs:  JNK  Extracellular signal responsive kinase  P38

JNK Functions ► JNK functions include regulation of immune and inflammatory responses, cell growth, apoptosis, and tumor formation.

JNK Activation ► Activation of JNK is mediated by a kinase cascade involving MAPK kinase and MAPK kinase kinase. Two MAPK kinase, MKK4 & MKK7 is required for JNK activation by inflammatory cytokines, whereas MKK4 is more important for JNK activation by stress signals.

Overview of Materials and Methods ► 293 cells (human embryonic kidney cells) were transected with either the empty vector pcDNA or an expression vector encoding HA-tagged CYLD. ► About 7 micrograms of protein lysates were subjected to IB using anti-CYLD. The transected HA-CYLD, endogenous CYLD, and some nonspecific protein bands are indicated.

Overview of Materials and Methods Continued ► 293 or HeLa cells (cancerous cells) were transected with either the control luciferase siRNA or CYLD-specific siRNA. About 20 micrograms of cell lysates were subjected to IB using anti-CYLD. ► Assays used in the experiment include:  Immunoblotting (IB)  In Vitro Kinase assay  Electrophoresis Mobility Shift Assay  RNAi assay  Immunecomplex kinase assay  Phospho-specific IB assay

Result # 1 ► CYLD is a negative regulator of JNK but not IKK in the TNF-alpha Signaling Pathway

Result # 1 cont.  To systematically analyze the role of CYLD regulation of cell signaling, a CYLD antibody was generated. ► A. The Ab detected endogenous and transfected CYLD. ► B. The Ab detected endogenous CYLD

Result # 1 Cont. ► Examined the effect of CYLD knockdown on cell signaling stimulated by the proinflammatory cytokine TNF-alpha. ► In both 293 & HeLa cells, TNF-alpha stimulated the catalytic activity of IKK and JNK as demonstrated by immunocomplex kinase assays.

Result # 1 continued ► Their hypothesis  IF endogenous CYLD serves as negative regulator of TNF-alpha stimulated cell signaling, the CYLD knockdown should result in hyperactivation of the specific kinases under the negative control of CYLD. ► Their conclusion  CYLD did not promote IKK activation in the TNF-alpha stimulated 293 cells or HeLa cells.

Result #1 continued ► Parallel Analyses using the same cells revealed that the CYLD knockdown markedly enhanced the activation of JNK.

Result #2 ► CYLD Knockdown Has No Effect on JNK Activation by a Stress Agent

Result #2 Cont. ► Activation of JNK by stress stimulus Anisomycin( antibiotic that activates stress-activated protein kinase) ► Incubation of 293 cells with anisomycin lead to strong activation of JNK ► JNK activated by anisomycin was not affected by CYLD knockdown ► TNF-  stimulated JNK activation showed enhancement of cytokine-kinase JNK response by CYLD knockdown.

Result #3 ► CYLD Negatively Regulates the Activation of MKK7

In vitro Kinase Assay ► First lyse the cell ► Immunoprecipitate the kinase using the appropriate antibody (IKKB or MAPK) ► Add buffer or protein of interest ► Analyze by autoradiography

Result #3 Cont. ► ► ► ► ► ► Effect of CYLD knockdown on TNF-  stimulated activation of MKK7 and MKK4. ► MKK7 was enhanced in CYLD knockdown cells ► MKK4 was not significantly enhanced in CYLD knockdown cells ► MKK7 is and upstream target of CYLD in JNK signaling ► Because MKK7 is enhanced by the knockdown CYLD must inhibit activation of MKK7

Result #4 ► CYLD Negatively Regulates JNK Activation by Diverse Stimuli

Result #4 Cont. ► CD40 cells did not exhibit significant signaling activity under unstimulated conditions ► Cross-linking of CD40 with its agonistic antibody lead to activation of IKK and JNK ► CYLD knockdown enhanced the the activation of JNK in anti-CD40-treated cells ►

Result #4 Cont. Anti-CD40 stimulated hyper activation of NF-  B in the CYLD knockdown Infection with CYLD-small hairpin RNA suppressed the expression of CYLD in BAJB B-cells CYLD knockdown enhanced JNK activation by LPS and IL-1  IKK activation was promoted in CYLD knockdown in LPS and IL-1 

Conclusions ► CYLD Is a Negative Regulator of JNK but Not IKK in the TNF-alpha Signaling Pathway ► CYLD Knockdown Has no effect on JNK Activation by a stress Agent ► CYLD Negatively Regulates the Activation ► of MKK7 ► CYLD Negatively Regulates JNK activation by diverse Stimuli

Conclusion ► How CYLD differentially regulates IKK and JNK is not completely understood, but one potential mechanism is attributed to the differential requirement of TRAFs in these signaling pathways. ► The findings that CYLD negatively regulates JNK as well as IKK provides an insight into the tumor suppressor function of CYLD.

Conclusion ► The IKK/NFkB pathway is well known for it involvement in cell survival and oncogenic transformation as well as immune responses. ► Evidence suggest that JNK is a critical factor involved in tumorgenisis.  The JNK signaling pathway is activated in various tumor cells.  JNK has been shown to promote cell growth and survial.  CYLD knockdown increases the magnitude of JNK transient activation but does not prolong the activation.

Reference ► ► ► ► n.htm n.htm n.htm